Ferroptosis: a new strategy for cardiovascular disease

Y Wang, J Wu - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
Cardiovascular disease (CVD) is currently one of the prevalent causes of human death. Iron
is one of the essential trace elements in the human body and a vital component of living …

Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases

Y Zou, H Shi, N Liu, H Wang, X Song… - Frontiers in …, 2023 - frontiersin.org
Heat shock protein 27 (HSP27) is a small chaperone protein that is overexpressed in a
variety of cellular stress states. It is involved in regulating proteostasis and protecting cells …

[HTML][HTML] Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in white populations

A Kheirkhah, JF Schachtl-Riess, C Lamina, S Di Maio… - Atherosclerosis, 2023 - Elsevier
Background and aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key
regulator of lipid homeostasis. A few earlier genome-wide association studies (GWAS) …

[HTML][HTML] Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis

S Jin, H Wang, X Zhang, M Song, B Liu… - Biomedicine & …, 2024 - Elsevier
Ferroptosis, distinct from apoptosis, necrosis, autophagy, and other types of cell death, is a
novel iron-dependent regulated cell death characterized by the accumulation of lipid …

[HTML][HTML] Ferroptosis in age-related vascular diseases: Molecular mechanisms and innovative therapeutic strategies

Y Dai, X Wei, T Jiang, Q Wang, Y Li, N Ruan… - Biomedicine & …, 2024 - Elsevier
Aging, an inevitable aspect of human existence, serves as one of the predominant risk
factors for vascular diseases. Delving into the mystery of vascular disease's …

Advances in integrating single-cell sequencing data to unravel the mechanism of ferroptosis in cancer

Z Du, Y Shi, J Tan - Briefings in Functional Genomics, 2024 - academic.oup.com
Ferroptosis, a commonly observed type of programmed cell death caused by abnormal
metabolic and biochemical mechanisms, is frequently triggered by cellular stress. The …

Proprotein convertase subtilisin/kexin type 9 as a drug target for abdominal aortic aneurysm

J Golledge, HS Lu, S Shah - Current Opinion in Lipidology, 2024 - journals.lww.com
Past research suggests that drugs that inhibit PCSK9 have potential as a novel therapy for
AAA to both limit aneurysm growth and reduce risk of cardiovascular events. A large …

Genetic association of lipid-lowering drugs with aortic aneurysms: a Mendelian randomization study

X Gao, W Luo, L Qu, M Yang, S Chen… - European Journal of …, 2024 - academic.oup.com
Aims The lack of effective pharmacotherapies for aortic aneurysms (AA) is a persistent
clinical challenge. Lipid metabolism plays an essential role in AA. However, the impact of …

Exploration of small molecule compounds targeting abdominal aortic aneurysm based on CMap database and molecular dynamics simulation

F Li, L Zhuo, F Xie, H Luo, Y Li, H Lin, X Li - Vascular, 2024 - journals.sagepub.com
Objective The mitigation of abdominal aortic aneurysm (AAA) growth through
pharmaceutical intervention offers the potential to avert the perils associated with AAA …

[PDF][PDF] A REVIEW OF ABDOMINAL AORTIC ANEURYSMS: RISK FACTORS, SCREENING, PHARMACOLOGICAL APPROACH.

DA BRIE, A JIANU, R POPESCU, T MARCOVICI… - …, 2024 - farmaciajournal.com
Most patients with abdominal aortic aneurysm (AAA) are asymptomatic, being diagnosed
during an imaging evaluation for other symptoms. AAA rupture is an emergency, being one …